News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stanford University Researchers Present Data on Highly Accurate Diagnostic Test for Preeclampsia in Development by Carmenta Bioscience



2/15/2013 9:12:13 AM

PALO ALTO, Calif.--(BUSINESS WIRE)--Carmenta Bioscience, Inc., in collaboration with researchers at Stanford University, today announced presentation of results from a retrospective clinical study at the 2013 Society of Maternal Fetal Medicine national meeting. The presentation revealed a new confirmatory diagnostic test highly accurate in distinguishing mothers with preeclampsia from a control group in the study. The underlying technology for the test was discovered by Carmenta’s co-founders, Dr. Atul Butte and Dr. Bruce Ling of Stanford University. Dr. Butte and Dr. Ling analyzed genomic and proteomic data from over 100 preeclamptic mothers to develop a novel, proprietary panel of serum proteins capable of diagnosis. Using advanced data mining techniques, they identified a multiplexed panel of biomarkers representing the broad diversity of biological processes associated with the condition.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES